Here, we demonstrated that IFN-γ/St.∆ppGpp combination therapy significantly inhibited tumor growth in mice, resulting in a higher survival rate in tumor-bearing mice compared with either IFN-γ or St.∆ppGpp alone. This evidence concerns the gene IFNG and neoplasm.